Studien
Laufende Phase-3-Studien aus ClinicalTrials.gov für die beobachteten Unternehmen. Die Einordnung der Redaktion erscheint erst nach Freigabe.
Zuletzt aktualisierte Profile
11. November 2026
Phase-3-Studien
| Substanz | Unternehmen | Indikation | Status | Register |
|---|---|---|---|---|
| 100mg Eluxadoline | Abbvie | Irritable Bowel Syndrome | Rekrutiert | NCT04880876 |
| 20vPnC | Pfizer | Pneumococcal Diseases | Rekrutiert | NCT07754539 |
| 25mg Eluxadoline | Abbvie | Irritable Bowel Syndrome | Rekrutiert | NCT04880876 |
| AAA617 | Novartis | Oligometastatic Prostate Cancer (OMPC) | Rekrutiert | NCT05939414 |
| AAA817 | Novartis | Prostate Cancer | Rekrutiert | NCT06855277 |
| ABBV-1480 | Abbvie | Non-Small Cell Lung Cancer | Rekrutiert | NCT07756645 |
| ABBV-706 | Abbvie | Small Cell Lung Cancer | Rekrutiert | NCT07365241 |
| Abiraterone acetate | Amgen | Metastatic Castration-resistant Prostate Cancer | Rekrutiert | NCT07213674 |
| ABP938 8 mg | Amgen | Neovascular Age-related Macular Degeneration, nAMD | Rekrutiert | NCT07614776 |
| Abrocitinib | Pfizer | Atopic Dermatitis | Rekrutiert | NCT06807281 |
| Actinium zadavotide guraxetan | AstraZeneca | Metastatic Castration-resistant Prostate Cancer | Rekrutiert | NCT07611110 |
| ADVATE | Takeda | Von Willebrand Disease (VWD) | Rekrutiert | NCT07129343 |
| Afimkibart | Roche | Moderately to Severely Active Crohns Disease | Rekrutiert | NCT06819891 |
| Alogliptin | Celltrion | T2DM, Diabete Type 2 | Rekrutiert | NCT07093476 |
| Alpelisib | Novartis | Lymphatic Malformations | Rekrutiert | NCT05948943 |
| Anifrolumab | AstraZeneca | Lupus Erythematosus, Systemic | Rekrutiert | NCT07751848 |
| Antithrombin concentrate | Sanofi | Hemophilia | Rekrutiert | NCT07285460 |
| Apraclonidine Ophthalmic Solution, 0.125% Unit Dose Preservative Free | Alcon | Ocular Hyperemia | Rekrutiert | NCT07531043 |
| Apremilast | Amgen | Active Juvenile Psoriatic Arthritis | Rekrutiert | NCT04804553 |
| ARPI | Novartis | Prostate Cancer | Rekrutiert | NCT06855277 |
| ASP2138 | Astellas | Gastric Adenocarcinoma, Gastroesophageal Junction (GEJ) Adenocarcinoma | Rekrutiert | NCT07673887 |
| Atezolizumab | Roche | Cancer | Rekrutiert | NCT05862285 |
| Avtozma | MSD | B-cell Acute Lymphoblastic Leukemia | Rekrutiert | NCT07570173 |
| AZD0120 | AstraZeneca | Newly Diagnosed Multiple Myeloma | Rekrutiert | NCT07764978 |
| AZD0486 | AstraZeneca | Large B-cell Lymphoma | Rekrutiert | NCT07215585 |
| Azithromycin | Sanofi | Lung Transplant Rejection | Rekrutiert | NCT06082037 |
| Baloxavir marboxil | Roche | Influenza, Human, Respiratory Tract Infections | Rekrutiert | NCT07827599 |
| Baricitinib | Eli Lilly | Diabetes Mellitus, Type 1 | Rekrutiert | NCT07222332 |
| Bedaquiline | Otsuka | Rifampicin-Resistant Pulmonary Tuberculosis, Multidrug-Resistant Pulmonary Tuberculosis | Rekrutiert | NCT07209761 |
| Belumosudil | Sanofi | Lung Transplant Rejection | Rekrutiert | NCT06082037 |
| Belzutifan | MSD | Renal Cell Carcinoma | Rekrutiert | NCT07227402 |
| Bendamustine | MSD | DLBCL, Diffuse Large B-Cell Lymphoma | Rekrutiert | NCT05139017 |
| Berobenatide | Pfizer | Obesity, Overweight | Rekrutiert | NCT07919678 |
| Best Available Treatment | Incyte Biosciences | Essential Thrombocythemia | Rekrutiert | NCT07623200 |
| Bevacizumab | Roche | Cancer | Rekrutiert | NCT05862285 |
| Bevacizumab | Merck KGaA | Metastatic Colorectal Cancer | Rekrutiert | NCT07549412 |
| Bevacizumab | Incyte Biosciences | CRC (Colorectal Cancer) | Rekrutiert | NCT07284849 |
| Bevacizumab | MSD | Ovarian Cancer, Ovarian Neoplasms | Rekrutiert | NCT07776691 |
| Bevacizumab | Eli Lilly | Ovarian Neoplasms, Fallopian Tube Neoplasms | Rekrutiert | NCT07213804 |
| BGB-43395 | BeiGene | HR+/HER2- Breast Cancer | Rekrutiert | NCT07492641 |
| Bimekizumab | UCB | Palmoplantar Pustulosis | Rekrutiert | NCT07219420 |
| BNT162b2 | BioNTech | COVID-19 Vaccines | Rekrutiert | NCT07798648 |
| BNT323 | BioNTech | Endometrial Cancer | Rekrutiert | NCT06340568 |
| BNT324 | BioNTech | Metastatic Castration-resistant Prostate Cancer | Rekrutiert | NCT07365995 |
| Brenipatide | Eli Lilly | Depressive Disorder, Major | Rekrutiert | NCT07412756 |
| Brivaracetam | UCB | Epilepsy | Rekrutiert | NCT04715646 |
| C.difficile | Pfizer | Clostridoides Difficile Associated Disease | Rekrutiert | NCT07282665 |
| Cagrilintide | Novo Nordisk, der dänische Diabetes-Pionier | Overweight, Obesity | Rekrutiert | NCT07745504 |
| CagriSema | Novo Nordisk, der dänische Diabetes-Pionier | Diabetes Mellitus, Type 2 | Rekrutiert | NCT07282613 |
| Centanafadine XR | Otsuka | Attention-deficit/Hyperactivity Disorder, Emotional Dysregulation | Rekrutiert | NCT07759154 |
| Cetrorelix acetate | Merck KGaA | Infertility | Rekrutiert | NCT07340827 |
| Cladribine High Dose | Merck KGaA | Generalized Myasthenia Gravis | Rekrutiert | NCT06463587 |
| Cladribine Low Dose | Merck KGaA | Generalized Myasthenia Gravis | Rekrutiert | NCT06463587 |
| Clotting factor concentrates or bypassing agents | Sanofi | Hemophilia | Rekrutiert | NCT07285460 |
| Concomitant Antibiotic Therapy | Takeda | Pouchitis | Rekrutiert | NCT06443502 |
| Corticosteroids | Incyte Biosciences | Chronic Graft-versus-host-disease | Rekrutiert | NCT06585774 |
| CT-P53 | Celltrion | Relapsing-remitting Multiple Sclerosis | Rekrutiert | NCT05906992 |
| CTX001 | Vertex Pharmaceuticals | Beta-Thalassemia, Thalassemia | Rekrutiert | NCT04208529 |
| Dapirolizumab pegol | UCB | Systemic Lupus Erythematosus | Rekrutiert | NCT04976322 |
| Dazodalibep | Amgen | Sjögren's Syndrome | Rekrutiert | NCT06747949 |
| Denecimig | Novo Nordisk, der dänische Diabetes-Pionier | Haemophilia A | Rekrutiert | NCT07830732 |
| Donanemab | Eli Lilly | Alzheimer Disease, Dementia | Rekrutiert | NCT07602582 |
| DZP | UCB | Systemic Lupus Erythematosus | Rekrutiert | NCT06617325 |
| EB-1020 164.4 mg | Otsuka | Attention Deficit Hyperactivity Disorder (ADHD) | Rekrutiert | NCT06931080 |
| EB-1020 328.8 mg | Otsuka | Attention Deficit Hyperactivity Disorder (ADHD) | Rekrutiert | NCT06931080 |
| Elritercept | Takeda | Myelofibrosis, Anemia | Rekrutiert | NCT07623161 |
| empagliflozin | Celltrion | T2DM, Diabete Type 2 | Rekrutiert | NCT07093476 |
| Enfortumab vedotin | Astellas | Urothelial Cancer, Urinary Bladder Neoplasms | Rekrutiert | NCT07566156 |
| Eptinezumab | Lundbeck | Migraine | Rekrutiert | NCT05164172 |
| Etavopivat | Novo Nordisk, der dänische Diabetes-Pionier | Sickle Cell Disease | Rekrutiert | NCT06612268 |
| Fazirsiran Injection | Takeda | Alpha1-Antitrypsin Deficiency | Rekrutiert | NCT06165341 |
| Fezolinetant | Astellas | Hot Flashes | Rekrutiert | NCT07829653 |
| Finerenone | Bayer AG | Left Ventricular Systolic Dysfunction, Heart Failure (Pediatric) | Rekrutiert | NCT07192952 |
| FOLFOX | Incyte Biosciences | CRC (Colorectal Cancer) | Rekrutiert | NCT07284849 |
| Lebrikizumab | Almirall | Nummular Eczema | Rekrutiert | NCT07542483 |
| levoleucovorin | Seattle Genetics | Colorectal Neoplasms | Rekrutiert | NCT05253651 |
| liposomal irinotecan | Astellas | Pancreatic Cancer, Metastatic Pancreatic Cancer | Rekrutiert | NCT07409272 |
| Metformin | Celltrion | T2DM, Diabete Type 2 | Rekrutiert | NCT07093476 |
| NBI-1065845 | Neurocrine Biosciences | Major Depressive Disorder | Rekrutiert | NCT06786624 |
| NBI-1117568 | Neurocrine Biosciences | Schizophrenia | Rekrutiert | NCT07105098 |
| Nucresiran | Alnylam Pharmaceuticals | Hereditary Transthyretin-Mediated Amyloidosis With Polyneuropathy, hATTR-PN | Rekrutiert | NCT07223203 |
| Obinutuzumab | BeiGene | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Rekrutiert | NCT06943872 |
| Osavampator | Neurocrine Biosciences | Major Depressive Disorder | Rekrutiert | NCT07196501 |
| Pembrolizumab | Novocure | Metastatic Non-small Cell Lung Cancer | Rekrutiert | NCT06216301 |
| Platinum based chemotherapy | Novocure | Metastatic Non-small Cell Lung Cancer | Rekrutiert | NCT06216301 |
| Povetacicept | Vertex Pharmaceuticals | Immunoglobulin A Nephropathy | Rekrutiert | NCT07807995 |
| Pumitamig | BioNTech | Extensive-stage Small-cell Lung Cancer | Rekrutiert | NCT06712355 |
| Rituximab | BeiGene | Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma | Rekrutiert | NCT06943872 |
| Sevabertinib | Bayer AG | Advanced Non-small Cell Lung Cancer, HER2 Mutation | Rekrutiert | NCT06452277 |
| SGT-003 | Solid Biosciences | Duchenne Muscular Dystrophy | Rekrutiert | NCT07160634 |
| Sonrotoclax | BeiGene | Mantle Cell Lymphoma, B Cell Lymphoma | Rekrutiert | NCT06742996 |
| STN1013800 eye drops in single dose containers | Santen | Acquired Blepharophimosis | Rekrutiert | NCT06514612 |
| STN1013800 ophthalmic solution | Santen | Blepharoptosis | Rekrutiert | NCT06683651 |
| Suzetrigine | Vertex Pharmaceuticals | Diabetic Peripheral Neuropathic Pain | Rekrutiert | NCT07231419 |
| trastuzumab | Seattle Genetics | Colorectal Neoplasms | Rekrutiert | NCT05253651 |
| tucatinib | Seattle Genetics | Colorectal Neoplasms | Rekrutiert | NCT05253651 |
| Valbenazine | Neurocrine Biosciences | Chorea, Huntington | Rekrutiert | NCT06312189 |
| VNZ | Vertex Pharmaceuticals | Cystic Fibrosis | Rekrutiert | NCT05844449 |
| Vutrisiran | Alnylam Pharmaceuticals | Transthyretin Amyloidosis (ATTR) With Cardiomyopathy | Rekrutiert | NCT06679946 |
| Zilebesiran | Alnylam Pharmaceuticals | High Risk Cardiovascular Disease, Hypertension | Rekrutiert | NCT07181109 |
| Amlenetug | Lundbeck | Multiple System Atrophy | Laufend | NCT06706622 |
| Anakinra | Swedish Orphan Biovitrum | Still's Disease, Juvenile Onset, Still's Disease, Adult-Onset | Laufend | NCT05814159 |
| Avexitide | Amylyx Pharmaceuticals | Post Bariatric Hypoglycemia | Laufend | NCT06747468 |
| BAY3723113 | Bayer AG | Obstructive Hypertrophic Cardiomyopathy | Laufend | NCT07023341 |
| Brentuximab vedotin | Seattle Genetics | Diffuse Large B-cell Lymphoma | Laufend | NCT04404283 |
| Darolutamide | Bayer AG | Biochemically Recurrent Prostate Cancer | Laufend | NCT05794906 |
| DE-117B Eye Drops | Santen | Open Angle Glaucoma, Ocular Hypertension | Laufend | NCT06666855 |
| Efanesoctocog alfa | Swedish Orphan Biovitrum | Haemophilia A (Moderate or Severe) | Laufend | NCT06716814 |
| KK8398 | Kyowa Kirin | Achondroplasia | Laufend | NCT06926491 |
| Loncastuximab Tesirine | ADC Therapeutics | Relapsed Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | Laufend | NCT04384484 |
| mRNA-1018-H5 | Moderna | Influenza | Laufend | NCT07496450 |
| mRNA-1403 | Moderna | Acute Gastroenteritis, Norovirus Acute Gastroenteritis | Laufend | NCT06592794 |
| Pacritinib | Swedish Orphan Biovitrum | Primary Myelofibrosis, Post-polycythemia Vera Myelofibrosis | Laufend | NCT03165734 |
| Rituximab | ADC Therapeutics | Relapsed Diffuse Large B-Cell Lymphoma, Refractory Diffuse Large B-Cell Lymphoma | Laufend | NCT04384484 |
| tapinarof cream, 1% | Organon | Plaque Psoriasis | Laufend | NCT05172726 |
| Temozolomide | Novocure | Glioblastoma | Laufend | NCT06556563 |
| TEV-56248 | Teva | Asthma | Laufend | NCT06052267 |
| Avatrombopag20 mg Oral Tablet | Swedish Orphan Biovitrum | Aplastic Anemia | Noch nicht begonnen | NCT07786922 |
| TEV-53408 Dose A | Teva | Vitiligo | Noch nicht begonnen | NCT07920211 |
| TEV-53408 Dose B | Teva | Vitiligo | Noch nicht begonnen | NCT07920211 |
Das ist die Registersicht, nicht die Pipeline der Unternehmen. Je Unternehmen stehen hier bis zu vier Phase-3-Substanzen, auf dem Steckbrief bis zu zwölf. Präklinik steht im Register nicht.